Amarin reported 8.77M in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acceleron Pharma XLRN:US $ -63662000 59K
Aerie Pharmaceuticals AERI:US $ -31501000 2.72M
Alnylam Pharmaceuticals ALNY:US $ -146160000 40.09M
Amarin AMRN:US 8.77M 10.1M
Arena Pharmaceuticals ARNA:US $ -144391000 12.4M
AstraZeneca AZN:LN 1.4B 366M
Biocryst Pharmaceuticals BCRX:US $ -29582000 21.8M
Epizyme EPZM:US $ -58231000 6.11M
Esperion Therapeutics ESPR:US $ -32533000 50.29M
GlaxoSmithKline GSK:LN 1.96B 281M
Halozyme Therapeutics HALO:US $ 93.05M 42.31M
Heron Therapeutics HRTX:US $ -60469000 8.36M
Intercept Pharmaceuticals ICPT:US $ 511K 29.7M
JAZZ PHA JAZZ:US -69590000 231.71M
Nektar Therapeutics NKTR:US $ -110205000 813K
Neurocrine Biosciences NBIX:US $ 67.8M 36.3M
Novartis NOVN:VX 3.4B 415M
Teva Pharmaceutical Industries TEVA:US 829M 35M